These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A case of recessive dystrophic epidermolysis bullosa treated with a cultured epidermal autograft. Mochizuki R; Oka Y; Hashimoto S; Shiraki E; Ogo M; Jimbo H; Nakano E; Fujiwara S; Nagano T; Nishigori C J Dermatol; 2021 Apr; 48(4):e165-e166. PubMed ID: 33523491 [No Abstract] [Full Text] [Related]
4. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study. Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111 [TBL] [Abstract][Full Text] [Related]
5. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa. Sacedón R; de Arriba MC; Martínez-Santamaría L; Maseda R; Herráiz-Gil S; Jiménez E; Rosales I; Quintana L; Illera N; García M; Butta N; Fernández-Bello I; Lwin SM; Fernández-Arquero M; León C; McGrath JA; Vicente MÁ; Del Río M; de Lucas R; Sánchez-Ramón S; Escámez MJ Br J Dermatol; 2023 Nov; 189(6):774-776. PubMed ID: 37655918 [No Abstract] [Full Text] [Related]
6. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. Solis DC; Teng C; Gorell ES; Barriga M; Nazaroff J; Li S; Lu Y; Bruckner A; Marinkovich MP; Tang JY J Am Acad Dermatol; 2021 Nov; 85(5):1296-1298. PubMed ID: 32896597 [No Abstract] [Full Text] [Related]
7. Intravenous allogeneic multilineage-differentiating stress-enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open-label study. Fujita Y; Nohara T; Takashima S; Natsuga K; Adachi M; Yoshida K; Shinkuma S; Takeichi T; Nakamura H; Wada O; Akiyama M; Ishiko A; Shimizu H J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e528-e531. PubMed ID: 33656198 [No Abstract] [Full Text] [Related]
8. The novel application of syringe needle in recessive dystrophic epidermolysis bullosa syndactyly release surgery. Wu C; Zhang W; Zhou K; Zhang X; Deng D J Am Acad Dermatol; 2024 May; 90(5):e165-e166. PubMed ID: 37977295 [No Abstract] [Full Text] [Related]
9. Rare case of eccrine poroma in recessive dystrophic epidermolysis bullosa. Moraes Campos L; Luiz da Silva D; Amorim VA; Malzoni ML; Fernandes Abbade LP; Roncada Haddad G Int J Dermatol; 2021 Jul; 60(7):e281-e283. PubMed ID: 33655513 [No Abstract] [Full Text] [Related]
10. Presentation of pleural effusion and dilated cardiomyopathy in a case of dystrophic epidermolysis bullosa. Arshad MA; Ayub MR; Zil-E-Ali A; Rashid S; Kazi MY; Pervaiz MA J Pak Med Assoc; 2020 Jun; 70(6):1106-1109. PubMed ID: 32810122 [TBL] [Abstract][Full Text] [Related]
11. Successful hybrid grafting of autologous cultured epidermis carrying a revertant mutation and split mesh skin in a patient with recessive dystrophic epidermolysis bullosa. Tanemura A; Mori S; Tonomura K; Yokoi K; Tanaka T; Inoie M; Takaki S; Shimbo T; Tamai K; Fujimoto M Eur J Dermatol; 2022 May; 32(3):417-419. PubMed ID: 36065546 [No Abstract] [Full Text] [Related]
12. Case of intermediate recessive dystrophic epidermolysis bullosa with negative LH7.2 staining. Yoshida K; Kobayashi M; Matsunaga Y; Kubo A; Ishiko A J Dermatol; 2020 Oct; 47(10):e370-e372. PubMed ID: 32656782 [No Abstract] [Full Text] [Related]
13. Complex genetic models in dystrophic epidermolysis bullosa families with marked intra-familial phenotypic heterogeneity. Chen F; Wang Y; Wang X; Yao Z; Li M J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e550-e553. PubMed ID: 35181940 [No Abstract] [Full Text] [Related]
14. Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critically appraised research paper. Doolan BJ; McGrath JA; Mellerio JE Br J Dermatol; 2024 Feb; 190(3):340-342. PubMed ID: 37936299 [No Abstract] [Full Text] [Related]
15. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. Mariath LM; Santin JT; Schuler-Faccini L; Kiszewski AE An Bras Dermatol; 2020; 95(5):551-569. PubMed ID: 32732072 [TBL] [Abstract][Full Text] [Related]
17. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327 [TBL] [Abstract][Full Text] [Related]
18. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations. von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783 [TBL] [Abstract][Full Text] [Related]
19. A case of dystrophic dentition in epidermolysis bullosa dystrophica. FARRIS CD Proc R Soc Med; 1963 Jul; 56(7):619-20. PubMed ID: 13944469 [No Abstract] [Full Text] [Related]
20. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]